Medical Marketing Insights

An HHS rule mandating that drug prices be included in ads was blocked mere hours before taking effect. How will this impact prescription drug marketing?

A recent study showed that virtual reality can improve medication adherence among HIV patients. Here’s what sponsors and CROs need to know about the potential of VR.

Almost a year later, healthcare providers are still struggling to meet GDPR data protection standards. If you’re still working on GDPR compliance, here are some of the major pitfalls to avoid.

2019 is the year of the patient. Here’s how CROs and sponsors can tap into patient-centric models to improve trial recruitment and retention.

These simple guidelines will help your medical practice avoid common risk pitfalls, achieve compliance, and embrace digital marketing.

The FDA’s new Action Plan focuses on safely reducing regulations — which creates opportunities for patients, medical providers, and marketers in the process.

Last year, the FDA put a considerable amount of energy into the digital health technology approval process. Will these efforts carry into 2018?

New guidelines from the FDA give clinical trials concrete recommendations on mHealth for today and confidence for the future.

Clinical trial sponsors know that any direct-to-patient advertising must secure IRB approval — but what does this mean in the digital age?

A friendly reminder that, with the recent HHS Office of Civil Rights announcement, covered entities may soon be facing some unwelcome audits. Now’s the time to review compliance.